FDA approves CARDAMYST from Milestone Pharmaceuticals USA, Inc. FDA Approval Dec. 15, 2025, 19:03 UTC Final approval of NDA #NDA #218571 for ETRIPAMIL. Decision date: 12/12/2025 Full text
There are no comments here yet...